Back to Results
First PageMeta Content
Bisphosphonates / Alendronic acid / Merck / Bone fractures / Osteopathies / Osteology / Osteoporosis / Merck & Co. / Bone density / Medicine / Health / Anatomy


[removed]FOSAMAX® (ALENDRONATE SODIUM) TABLETS AND ORAL SOLUTION DESCRIPTION FOSAMAX* (alendronate sodium) is a bisphosphonate that acts as a specific inhibitor of osteoclastmediated bone resorption. Bisphosphonates are
Add to Reading List

Document Date: 2004-09-14 08:01:29

Open Document

File Size: 165,43 KB

Share Result on Facebook

Company

MERCK & CO. Inc. / /

Country

United States / /

Currency

BMD / /

Event

FDA Phase / /

IndustryTerm

osteoporosis treatment / osteoporosis prevention / mg oral solution / prevention of osteoporosis / treatment of osteoporosis / /

MedicalCondition

kidney failure / Renal Insufficiency / kyphosis / deformity / disease / disorder / osteoporosis / glucocorticoid-requiring diseases / bone resorption / renal failure / chronic / Hepatic Insufficiency / postmenopausal osteoporosis / /

MedicalTreatment

estrogen therapy / HRT / hormone replacement therapy / /

Organization

Concomitant administration / /

Product

FOSAMAX / vitamin D / prednisone / ranitidine / etidronate disodium / ALENDRONATE SODIUM / testosterone / FOSAMAX® (alendronate sodium) Tablets / /

Technology

Pharmacokinetics / Pharmacodynamics / x-ray / /

SocialTag